The global network point-of-care (POC) glucose testing market, valued at USD 1,387.65 million in 2024, is projected to reach USD 2,109.01 million by 2034, growing at a steady CAGR of 4.3% between 2025 and 2034. This growth underscores the increasing importance of integrated POC glucose testing devices in hospitals, clinics, and other healthcare settings, as diabetes continues to pose a critical global health challenge.

Market Overview

Network point-of-care glucose testing refers to connected glucose monitoring systems that integrate with hospital information systems (HIS), electronic medical records (EMR), and laboratory information systems (LIS). Unlike standalone devices, these network-enabled systems streamline workflows, reduce transcription errors, and enhance real-time data sharing between patients and healthcare providers.

The rising global prevalence of diabetes mellitus, coupled with growing demand for accurate and timely glucose monitoring, has accelerated the adoption of these systems. Hospitals and clinics increasingly favor network-enabled glucose testing devices because they support clinical decision-making, regulatory compliance, and patient safety.

Additionally, with the rise of connected healthcare ecosystems, networked POC glucose testing solutions are becoming essential for achieving integrated patient management. Their role is expanding not only in acute care but also in long-term disease monitoring, reflecting a shift toward digital healthcare infrastructure.

Key Market Growth Drivers

The growth of the global network POC glucose testing market is fueled by multiple factors:

1. Rising Global Diabetes Burden – According to the International Diabetes Federation (IDF), over 530 million adults worldwide live with diabetes, a figure expected to grow significantly by 2040. This rising prevalence is driving continuous demand for glucose monitoring solutions.

2. Shift Toward Connected Healthcare – Hospitals and healthcare systems are embracing digital solutions that enable real-time data sharing. Network-enabled glucose meters help clinicians make faster and more informed decisions.

3. Regulatory Emphasis on Patient Safety – Healthcare accreditation agencies and regulators mandate accurate glucose monitoring, especially in hospital settings. Networked POC systems ensure compliance by reducing human error.

4. Workflow Efficiency in Healthcare Facilities – Integration with EMRs and HIS reduces administrative burdens, eliminates manual transcription, and streamlines billing, thereby improving operational efficiency.

5. Technological Advancements – Ongoing innovations in wireless connectivity, Bluetooth, and IoT integration are enhancing device accuracy, portability, and real-time data sharing capabilities.

6. Growing Demand in Emerging Markets – Rapid improvements in healthcare infrastructure in Asia-Pacific, Latin America, and the Middle East are opening new opportunities for network POC glucose testing systems.

Market Challenges

While the market outlook is positive, certain barriers may slow down adoption:

• High Implementation Costs – Network-enabled glucose systems are more expensive than traditional POC devices, making them less accessible in resource-constrained healthcare facilities.

• Data Security Concerns – Integration with EMRs raises issues related to cybersecurity and patient privacy, especially under regulations such as HIPAA and GDPR.

• Lack of Technical Expertise – Smaller healthcare institutions may struggle to implement and manage integrated network solutions.

• Limited Awareness in Developing Regions – Many healthcare providers in emerging markets still rely on traditional glucose meters due to lack of awareness and budget constraints.

• Maintenance and Connectivity Issues – Ensuring stable connectivity and system interoperability can be challenging, particularly in rural and underdeveloped healthcare settings.

Market Segmentation

The network point-of-care glucose testing market is segmented based on product type, end user, and region.

1. By Product Type

• Handheld Devices – Portable, widely used in hospitals, clinics, and long-term care facilities due to convenience and rapid results.

• Benchtop Devices – Preferred in laboratory and hospital settings where high-volume glucose testing and advanced data connectivity are required.

2. By End User

• Hospitals – Largest end-user segment, as hospitals rely heavily on network-enabled glucose meters for patient monitoring, compliance, and workflow optimization.

• Clinics – Increasing adoption due to the need for faster diagnosis and treatment in outpatient settings.

• Home Care Settings – Growing slowly but expected to expand with the rising availability of patient-friendly connected glucose monitoring devices.

• Others – Includes nursing homes, diagnostic laboratories, and ambulatory care centers.

Regional Analysis

The adoption of network POC glucose testing solutions varies across regions:

North America

• Holds the largest market share due to advanced healthcare infrastructure, high diabetes prevalence, and early adoption of digital health solutions.

• The U.S. leads the region, supported by strong regulatory frameworks and widespread use of EMR systems.

Europe

• Second-largest market, with growing demand for connected glucose monitoring systems.

• Countries like Germany, the U.K., and France emphasize regulatory compliance, data security, and integration with hospital IT infrastructure.

Asia-Pacific

• Expected to grow at the fastest rate due to the rising diabetes population in China, India, and Southeast Asia.

• Rapid urbanization, government initiatives in healthcare digitization, and increasing hospital investments are fueling market expansion.

Latin America

• Moderate growth driven by the adoption of digital healthcare in Brazil and Mexico.

• Increasing awareness of diabetes management and healthcare IT is supporting gradual adoption.

Middle East & Africa

• Early stage of adoption but showing potential with rising healthcare modernization efforts in Saudi Arabia, UAE, and South Africa.

• Government programs to combat chronic diseases are likely to support growth in this region.

Key Companies

• ACON Laboratories, Inc.
• Abbott Laboratories
• ARKRAY, Inc.
• Ascensia Diabetes Care Holdings AG
• Danaher Corporation (HemoCue subsidiary)
• DexCom, Inc.
• EKF Diagnostics Holdings plc.
• F. Hoffmann-La Roche Ltd.
• LifeScan, Inc. (Platinum Equity Advisors, LLC subsidiary)
• Medtronic plc
• Nipro Corporation Japan
• Nova Biomedical Corporation
• Prodigy Diabetes Care, LLC
• Terumo Corporation
• Trividia Health, Inc.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:

https://www.polarismarketresearch.com/industry-analysis/network-point-of-care-glucose-testing-market 

Future Outlook

The future of the network point-of-care glucose testing market will be shaped by:

• Wider Adoption of IoT and AI – Integration of artificial intelligence and machine learning will enable predictive insights and smarter glucose management.

• Expansion of Telemedicine and Remote Patient Monitoring – Connected POC glucose meters will play a pivotal role in remote healthcare delivery.

• Focus on Patient-centric Solutions – Manufacturers will prioritize user-friendly devices for both clinical and home settings.

• Growth in Emerging Markets – As healthcare infrastructure improves, Asia-Pacific, Latin America, and Africa will represent lucrative growth opportunities.

• Regulatory Alignment and Standardization – Governments and agencies will increasingly push for interoperability standards to streamline data integration.

Conclusion

The global network point-of-care glucose testing market is poised for steady growth, expected to expand from USD 1,387.65 million in 2024 to USD 2,109.01 million by 2034 at a CAGR of 4.3%. Rising diabetes prevalence, the global shift toward connected healthcare, and growing demand for accurate, integrated glucose monitoring are the primary forces driving this expansion.

With major players such as Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Nova Biomedical leading innovation, the market is set to witness continued advancements in connectivity, data integration, and patient-centered care. As healthcare systems worldwide move toward digitization, network point-of-care glucose testing will remain an essential component of effective diabetes management and clinical decision-making.

More Trending Latest Reports By Polaris Market Research:

Vaginitis Therapeutics Market

Synthetic Graphite Market

Location Analytics Market

Internet Of Things Analytics Market

Ready To Drink Tea And Coffee Market

Vitamin and mineral premixes market